P
PLx Pharma Inc
F:1D5A
PLx Pharma Inc
F:1D5A
Price:
0.0005
EUR
Market Closed
Market Cap:
€210k
Balance Sheet
Balance Sheet Decomposition
PLx Pharma Inc
PLx Pharma Inc
Balance Sheet Decomposition is not available for
PLx Pharma Inc
PLx Pharma Inc
Balance Sheet
PLx Pharma Inc
PLx Pharma Inc
Currency: USD
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1
|
4
|
27
|
5
|
0
|
24
|
14
|
14
|
22
|
69
|
|
| Cash Equivalents |
1
|
4
|
27
|
5
|
0
|
24
|
14
|
14
|
22
|
69
|
|
| Short-Term Investments |
0
|
0
|
0
|
27
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
|
| Total Current Assets |
1
|
4
|
27
|
32
|
0
|
26
|
15
|
14
|
23
|
73
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
|
| Total Assets |
1
N/A
|
4
+174%
|
27
+575%
|
32
+19%
|
1
-98%
|
29
+4 553%
|
18
-36%
|
19
+1%
|
27
+44%
|
77
+188%
|
|
| Liabilities | |||||||||||
| Accrued Liabilities |
0
|
1
|
1
|
2
|
0
|
1
|
1
|
2
|
2
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
1
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
1
|
1
|
2
|
3
|
2
|
5
|
6
|
4
|
12
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
7
|
4
|
1
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
15
|
3
|
10
|
13
|
13
|
|
| Total Liabilities |
0
N/A
|
1
+413%
|
1
+54%
|
2
+28%
|
3
+83%
|
24
+724%
|
12
-51%
|
17
+42%
|
16
-5%
|
25
+54%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
14
|
21
|
16
|
|
| Retained Earnings |
0
|
0
|
22
|
41
|
52
|
67
|
66
|
87
|
102
|
148
|
|
| Additional Paid In Capital |
0
|
0
|
48
|
72
|
50
|
72
|
73
|
75
|
91
|
184
|
|
| Other Equity |
1
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
3
+145%
|
26
+708%
|
31
+19%
|
2
N/A
|
5
N/A
|
6
+39%
|
2
-76%
|
10
+566%
|
52
+395%
|
|
| Total Liabilities & Equity |
1
N/A
|
4
+174%
|
27
+575%
|
32
+19%
|
1
-98%
|
29
+4 553%
|
18
-36%
|
19
+1%
|
27
+44%
|
77
+188%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
9
|
9
|
9
|
9
|
14
|
28
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
